Uconn Health

Farmington, Connecticut 06032

17 studies enrolling now · 75 studies all time

What they study most

Abnormal Uterine Bleeding, Adenomyosis, Adnexal Mass, Adnexal Surgery, Age-Related Immunodeficiency, Aging, Alcohol Use Disorder, Alcoholism, Atopic Dermatitis, Blood Pressure, Brain Tumor, Breast Cancer

Studies at this site

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• Effects of Hard Gum Chewing on Facial Soft Tissue Morphology — Recruiting now
• Individualized Assessment and Treatment for TMD — Recruiting now
• A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors — Recruiting now
• Novel Approaches to the Treatment of Hypothyroidism — Recruiting now
• Targeting Aging With a Ketone Ester for Function in Frailty — Recruiting now
• Integrated Treatment for Enhancing Growth in Recovery During Adolescence — Recruiting now
• Cognitive Remediation — Recruiting now
• The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults — Recruiting now
• Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait — Recruiting now
• Depo-Medrol on Psoas After LLIF — Recruiting now
• Impact of Educational Videos on Pre-operative Anxiety — Enrolling by invitation
• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — Running, not enrolling
• A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have — Running, not enrolling
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease (SCD) — Running, not enrolling
• Brain-Training Treatment for Long COVID in Older Adults — Running, not enrolling
• Predictors of Cognitive Outcomes in Geriatric Depression — Running, not enrolling
• Meals 4 Moms: A Multilevel Community-based Lifestyle Intervention for GDM — Stopped early
• Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome — Stopped early
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Cognitive Fitness for Depression in Older Adults — Completed
• Walnuts and Colon Health — Completed
• Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
• Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia — Completed
• Addictive Potential of LCCs in Dual Users — Completed
• Effectiveness of the Educator Well-being Program — Enrolling by invitation
• A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color — Completed
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab — Completed
• Promoting Self-Management of Breast and Nipple Pain With Technology (PROMPT) for Breastfeeding Women Study — Completed
• Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
• Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection — Completed
• Characterizing Orthodontic Tooth Movement With Photographic Scans — Completed
• POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) — Stopped early
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
• Impact of Cigar Flavor in Dual Users — Completed
• P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation — Running, not enrolling
• A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women — Completed
• Opioid Package Prototype (OPP) — Starting soon
• CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC — Running, not enrolling
• Effects of Transportation Choices on Commuter Health — Completed
• Husky Reads Effectiveness in Increasing Produce Preference and Food Group Identification in Preschool Children — Completed
• LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma — Completed
• Sickle Cell Hemoglobinopathies and Bone Health — Running, not enrolling
• TMD Online Program for Pain Management — Completed
• Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults — Running, not enrolling
• Home Air Filtration for Traffic-Related Air Pollution — Completed